Aims and scope
JNNP’s ambition is to publish the most ground-breaking and cutting-edge research from around the world. Encompassing the entire genre of neurological sciences, our focus is on the common disorders (stroke, multiple sclerosis, Parkinson’s disease, epilepsy, peripheral neuropathy, subarachnoid haemorrhage and neuropsychiatry), but with a keen interest in the Gordian knots that present themselves in the field, such as ALS. With early online publication, regular podcasts and an immense archive collection (with the longest half-life of any journal in clinical neuroscience), JNNP is a trail-blazer and not a follower. Subscribers to JNNP also have access to Practical Neurology and the Journal of NeuroInterventional Surgery.
JNNP is owned by BMJ.
Practical Neurology is a bi-monthly educational supplement, free to JNNP subscribers. Each issue of Practical Neurology publishes reviews and essays from eminent neurologists from around the world, as well as educational material to test your knowledge. Papers are rigorously edited to present the working neurologist with accessible, engaging, up-to-date information.
5% for original research submitted in 2016
Time from submission to first decision
Time from acceptance to publication
18 days (online)
8 months (print)
18 times per year (including PN)
Index Medicus (Medline), ISI Current Contents (Web of Science), Excerpta Medica (Embase)
ISSN of JNNP
ISSN of JNNP Online
For all contact information please refer to the Contact Us page.
Please refer to the Instructions for Authors
Rights and permissions
The BMJ Publishing Group is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting accurate, transparent reporting of research studies. The BMJ Group is a sponsor of its activities.
BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.